Fed. Circ. OKs AbbVie's Double-Patenting Win In Humira Case
The Federal Circuit on Thursday affirmed a lower court ruling invalidating a Mathilda and Terence Kennedy Institute of Rheumatology Trust arthritis treatment patent for double-patenting, freeing AbbVie Inc. from having to...To view the full article, register now.
Already a subscriber? Click here to view full article